Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
Conditions:   Percutaneous Coronary Intervention (PCI);   Atrial Fibrillation (AF);   Oral Anticoagulation;   P2Y12 Inhibitor Interventions:   Drug: P2Y12 inhibitors (clopidogrel, ticagrelor, prasugrel);   Drug: Aspirin;   Drug: DOAC Sponsors:   Insel Gruppe AG, University Hospital Bern;   Sahajanand Medical Technologies Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2023 Category: Research Source Type: clinical trials

Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
Conditions:   Percutaneous Coronary Intervention (PCI);   Atrial Fibrillation (AF);   Oral Anticoagulation;   P2Y12 Inhibitor Interventions:   Drug: P2Y12 inhibitor;   Drug: Aspirin;   Drug: DOAC Sponsors:   Insel Gruppe AG, University Hospital Bern;   Sahajanand Medical Technologies Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2023 Category: Research Source Type: clinical trials

Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial
Conditions:   Atherosclerosis;   Cardiovascular Diseases;   Drug Effect Intervention:   Drug: Aspirin Sponsor:   Tor Biering-Sørensen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials